9149 Phase II study of bevacizumab in combination with cisplatin and docetaxel as first line treatment of patients (p) with metastatic non squamous non-small-cell lung cancer (NSCLC)
Ferrer, N., Cobo, M., Paredes, A., Méndez, M., Muñoz-Langa, J., Rueda, A., de Mon, M. Álvarez, Sánchez-Hernández, A., Gallego, R., Torrego, J.C.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71862-2
Date:
September, 2009
File:
PDF, 49 KB
english, 2009
File converter
More search results
More benefits 
